PKM and hepatocellular carcinoma: Our data suggest that lncRNA-SOX2OT upregulation in HCC cells may result in enhanced PKM2 levels in the HCC microenvironment, which subsequently activate the glycolytic pathway and thereby promote tumorigenesis.